Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    NCT01305109
Previous Study | Return to List | Next Study

A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E (ROTAVAC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by Bharat Biotech International Limited.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Ministry of Science and Technology, India
PATH
Information provided by (Responsible Party):
Bharat Biotech International Limited
ClinicalTrials.gov Identifier:
NCT01305109
First received: February 18, 2011
Last updated: June 9, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
No publications provided by Bharat Biotech International Limited

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):